Medpace Holdings Inc. (MEDP)
Medpace Being Investigated on Behalf of Medpace Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
The Schall Law Firm Is Starting An Inquiry Into Medpace Holdings Inc For Violations Of Securities Regulations And Investors Are Invited To Join
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medpace Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MEDP
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
Medpace Holdings Inc Is Being Looked Into By The Schall Law Firm For Possible Securities Fraud And Impacted Stockholders Are Urged To Participate
LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Levi & Korsinsky Reminds Shareholders of an Investigation into Medpace Holdings, Inc. (MEDP) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
Investors With Losses In Medpace Holdings Inc Are Invited To Join The Schall Law Firm In An Investigation Into Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Investigation Has Commenced on Behalf of Medpace Holdings, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MEDP Losses
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
The Schall Law Firm Urges Shareholders To Participate In A Securities Fraud Inquiry Into Medpace Holdings Inc
LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
MEDP STOCK ALERT: Levi & Korsinsky Notifies Medpace Holdings, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
The Schall Law Firm Is Seeking Investors To Join A Securities Fraud Investigation Into Medpace Holdings Inc
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Medpace stock is up 69% since my original buy rating, backed by strong profitability and cash flow generation. Q2 earnings show continued growth and backlog strength, with potential for further value creation above opportunities of equal risk. Forward estimates on conservative assumptions imply the intrinsic worth of the business is above $400/share.
Lost Money on Medpace Holdings, Inc.(MEDP)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violations of federal securities laws. On July 22, 2024, after market hours, MedPace announced mixed financial results for the second quarter of 2024 and then slashed its revenue guidance for the third quarter and remainder of the year.
